Life sciences news
-
Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology
Tuesday December 12th 2023
Read more
-
KU Leuven formally opens new research centre for innovative gene therapy
Friday December 8th 2023
Read more
-
VUB team develops nanobody technology against liver inflammation
Monday December 4th 2023
Read more
-
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
Monday December 4th 2023
Read more
-
Celyad announces management change
Friday December 1st 2023
Read more
-
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
Thursday November 30th 2023
Read more
-
Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer
Wednesday November 29th 2023
Read more
-
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
Wednesday November 29th 2023
Read more
-
Your news here?
-
argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia
Tuesday November 28th 2023
Read more
-
Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion
Wednesday November 22nd 2023
Read more
-
argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis
Thursday November 16th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator